Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Other Current Receivables

: $186 Mil (As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

Takeda Pharmaceutical Co's Other Current Receivables for the quarter that ended in Dec. 2023 was $186 Mil.

Takeda Pharmaceutical Co's quarterly Other Current Receivables declined from Jun. 2023 ($230.52 Mil) to Sep. 2023 ($221.44 Mil) but then stayed the same from Sep. 2023 ($221.44 Mil) to Dec. 2023 ($186.48 Mil).

Takeda Pharmaceutical Co's annual Other Current Receivables declined from Mar. 2021 ($224.75 Mil) to Mar. 2022 ($118.69 Mil) and declined from Mar. 2022 ($118.69 Mil) to Mar. 2023 ($52.39 Mil).

Takeda Pharmaceutical Co Other Current Receivables Historical Data

The historical data trend for Takeda Pharmaceutical Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Current Receivables

Get a 7-Day Free Trial

454.53

647.94

224.75

118.69

52.39

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Receivables	Get a 7-Day Free Trial															537.78	52.39	230.52	221.44	186.48

Takeda Pharmaceutical Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

Takeda Pharmaceutical Co Other Current Receivables Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Other Current Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (NYSE:TAK) » Definitions » Other Current Receivables

Comparable Companies

Traded in Other Exchanges

TKPHF:USA TAK:Mexico 4502:Japan 4502:Japan 4502:Japan 4502:Japan TKDA:Germany TKD:Germany TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.